UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5751
PUT
Fortuna Silver Mines
FSM
$3.07B
| $556K | ﹤0.01% |
129,600
| – | – |
|
5752
Mistras Group
MG
$512M
| $556K | ﹤0.01% |
61,335
+42,992
| +234% | +$423K |
|
5753
Douglas Dynamics
PLOW
$1.02B
| $555K | ﹤0.01% |
23,471
-126
| -0.5% | -$3.19K |
|
5754
Rigetti Computing Warrants
RGTIW
$181M
| $554K | ﹤0.01% |
87,412
+26,758
| +44% | +$35.6K |
|
5755
Lyell Immunopharma
LYEL
$360M
| $553K | ﹤0.01% |
43,214
+37,778
| +695% | +$749K |
|
5756
MacroGenics
MGNX
$257M
| $552K | ﹤0.01% |
169,959
+83,947
| +98% | +$302K |
|
5757
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.06B
| $552K | ﹤0.01% |
25,630
+1,244
| +5% | +$27.2K |
|
5758
FRP Holdings
FRPH
$421M
| $552K | ﹤0.01% |
18,015
+10,824
| +151% | +$331K |
|
5759
Sera Prognostics
SERA
$81.1M
| $546K | ﹤0.01% |
67,046
+24,873
| +59% | +$183K |
|
5760
MasterCraft Boat Holdings
MCFT
$590M
| $546K | ﹤0.01% |
28,613
+20,686
| +261% | +$396K |
|
5761
4D Molecular Therapeutics
FDMT
$562M
| $543K | ﹤0.01% |
97,564
+17,275
| +22% | +$136K |
|
5762
Outlook Therapeutics
OTLK
$191M
| $542K | ﹤0.01% |
286,644
+279,488
| +3,906% | +$1.15M |
|
|
SBDS
5763
DELISTED
Solo Brands Inc
SBDS
| $541K | ﹤0.01% |
11,865
+11,520
| +3,339% | +$571K |
|
|
PHD
5764
DELISTED
Pioneer Floating Rate Fund
PHD
| $541K | ﹤0.01% |
55,859
+1,778
| +3% | +$17.5K |
|
|
HONE
5765
DELISTED
HarborOne Bancorp
HONE
| $540K | ﹤0.01% |
45,642
+14,825
| +48% | +$188K |
|
5766
Clover Health Investments
CLOV
$2.51B
| $540K | ﹤0.01% |
171,318
+138,772
| +426% | +$496K |
|
5767
Arq
ARQ
$89.3M
| $539K | ﹤0.01% |
71,250
+28,017
| +65% | +$184K |
|
5768
Vishay Precision Group
VPG
$914M
| $539K | ﹤0.01% |
22,978
+14,270
| +164% | +$334K |
|
5769
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$406M
| $537K | ﹤0.01% |
17,147
+16,150
| +1,620% | +$520K |
|
5770
CrossAmerica Partners
CAPL
$817M
| $537K | ﹤0.01% |
24,413
-209
| -0.8% | -$4.41K |
|
5771
PUT
Patterson-UTI
PTEN
$3.76B
| $537K | ﹤0.01% |
+65,000
| New | +$521K |
|
5772
Gold Royalty Corp
GROY
$699M
| $536K | ﹤0.01% |
443,379
+248,946
| +128% | +$332K |
|
5773
AMES National
ATLO
$277M
| $536K | ﹤0.01% |
32,609
-10,538
| -24% | -$182K |
|
5774
Travelzoo
TZOO
$75.4M
| $535K | ﹤0.01% |
26,812
+21,938
| +450% | +$378K |
|
5775
Intercorp Financial Services
IFS
$6.55B
| $535K | ﹤0.01% |
+18,231
| New | +$509K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.